These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3550640)

  • 1. [Effects of SIN-1 on the oxygenated metabolism of arachidonic acid in blood platelets and endothelial cells].
    Lagarde M; Croset M; Bordet JC
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):216-7. PubMed ID: 3550640
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential effect of SIN-1 on thromboxane and prostacyclin formation in platelets and endothelial cells.
    Lagarde M; Bordet JC; Croset M
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S95-7. PubMed ID: 2484709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of molsidomine, an anti-anginal drug, on arachidonic acid metabolism in human platelets.
    Croset M; Lagarde M
    Biomed Biochim Acta; 1984; 43(8-9):S354-7. PubMed ID: 6440549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of prostacyclin/thromboxane formation by molsidomine during platelet-endothelial cell interactions.
    Bordet JC; Lagarde M
    Biochem Pharmacol; 1988 Oct; 37(20):3911-4. PubMed ID: 3142481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of molsidomine and its metabolites on polymorphonuclear cell function and arachidonic acid metabolism.
    Schröder H; Ney P; Woditsch I; Schrör K
    Prog Clin Biol Res; 1989; 301():553-9. PubMed ID: 2552466
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of SIN-1 on the metabolism of arachidonic acid in vascular smooth muscle cells in culture].
    Dorian B; Daret D; Larrue J
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):235-7. PubMed ID: 3550645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of SIN-1 on the early phases of blood platelet activation].
    Weill D; Maclouf J; Rendu F; Levy-Toledano S
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):212. PubMed ID: 3550637
    [No Abstract]   [Full Text] [Related]  

  • 8. Arachidonic acid metabolism in platelets and endothelial cells.
    Marcus A; Weksler B; Jaffe E; Safier L; Ullman H; Broekman M; Dorso C; Brown S
    Prog Lipid Res; 1981; 20():431-4. PubMed ID: 6804972
    [No Abstract]   [Full Text] [Related]  

  • 9. Uptake and effect on arachidonic acid oxygenation of some icosaenoic acids in human platelets.
    Lagarde M; Drouot B; Guichardant M; Dechavanne M
    Biomed Biochim Acta; 1984; 43(8-9):S319-22. PubMed ID: 6097236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of F2-isoprostanes during the oxidation of human low density lipoprotein by peroxynitrite.
    Moore KP; Darley-Usmar V; Morrow J; Roberts LJ
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():225-7. PubMed ID: 7732839
    [No Abstract]   [Full Text] [Related]  

  • 11. Arachidonic acid metabolism in endothelial cells and platelets.
    Marcus AJ; Broekman MJ; Weksler BB; Jaffe EA; Safier LB; Ullman HL; Islam N; Tack-Goldman K
    Ann N Y Acad Sci; 1982; 401():195-202. PubMed ID: 6762834
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prostanoid metabolism and its regulatory mechanisms in platelets and endothelial cells].
    Fujimoto T; Yamazaki H
    Nihon Rinsho; 1989 Apr; 47(4):788-93. PubMed ID: 2664265
    [No Abstract]   [Full Text] [Related]  

  • 13. SIN-1, the main metabolite of molsidomine, inhibits prostaglandin endoperoxide analogue- and arachidonic acid-induced platelet aggregation as well as platelet thromboxane A2 formation.
    Block HU; Förster W; Heinroth I
    Arzneimittelforschung; 1982; 32(3):189-94. PubMed ID: 6896278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arachidonic acid metabolites, blood platelets and vascular endothelium in cerebrovascular disease].
    Vapaatalo H
    Duodecim; 1989; 105(7):591-602. PubMed ID: 2656209
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms of hemostasis and therapy of thrombosis: new concepts based on the metabolism of arachidonic acid by platelets and endothelial cells.
    Silver MJ
    Adv Pharmacol Chemother; 1981; 18():1-47. PubMed ID: 6275687
    [No Abstract]   [Full Text] [Related]  

  • 16. 1-Phenyl-3-pyrazolidone: an inhibitor of arachidonate oxidation in lung and platelets [proceedings].
    Blackwell GJ; Flower RJ
    Br J Pharmacol; 1978 Jun; 63(2):360P. PubMed ID: 667442
    [No Abstract]   [Full Text] [Related]  

  • 17. Arachidonic acid and eicosapentaenoic acid metabolism in platelets and vessel walls.
    Weber PC; Fischer S
    Med Biol; 1984; 62(2):129. PubMed ID: 6088906
    [No Abstract]   [Full Text] [Related]  

  • 18. Dependence of arachidonic acid (AA) metabolization in human blood platelets on reduced coenzymes.
    Lösche W; Bosia A; Caruso D; Spangenberg P; Pescarmona GP; Hofmann J; Galli G; Arese P; Paoletti R; Till U
    Biomed Biochim Acta; 1984; 43(8-9):S362-5. PubMed ID: 6440551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redox metabolism regulation in normal and metabolically altered human platelets.
    Bosia A; Ghigo D; Bussolino F; Treves S; Pescarmona GP; Spangenberg P; Till U
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():23-6. PubMed ID: 3159206
    [No Abstract]   [Full Text] [Related]  

  • 20. [Arachidonic acid metabolism in platelets].
    Harada Y; Katori M
    Rinsho Byori; 1985 Jul; 33(7):722-5. PubMed ID: 4068260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.